These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23084373)

  • 1. Feasibility of an early Alzheimer's disease immunosignature diagnostic test.
    Restrepo L; Stafford P; Johnston SA
    J Neuroimmunol; 2013 Jan; 254(1-2):154-60. PubMed ID: 23084373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
    Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
    J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease.
    Thomas P; Wang YJ; Zhong JH; Kosaraju S; O'Callaghan NJ; Zhou XF; Fenech M
    Mutat Res; 2009 Feb; 661(1-2):25-34. PubMed ID: 19027755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of immunosignatures to the assessment of Alzheimer's disease.
    Restrepo L; Stafford P; Magee DM; Johnston SA
    Ann Neurol; 2011 Aug; 70(2):286-95. PubMed ID: 21823156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice.
    Cao C; Wang L; Lin X; Mamcarz M; Zhang C; Bai G; Nong J; Sussman S; Arendash G
    J Alzheimers Dis; 2011; 25(2):323-35. PubMed ID: 21422521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
    Bonardi C; de Pulford F; Jennings D; Pardon MC
    Behav Brain Res; 2011 Sep; 222(1):89-97. PubMed ID: 21440575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse.
    Jyoti A; Plano A; Riedel G; Platt B
    J Alzheimers Dis; 2010; 22(3):873-87. PubMed ID: 20858963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of interneuron populations and correlation with amyloid-β deposition in the olfactory cortex of an AβPP/PS1 transgenic mouse model of Alzheimer's disease.
    Saiz-Sanchez D; Ubeda-Bañon I; De la Rosa-Prieto C; Martinez-Marcos A
    J Alzheimers Dis; 2012; 31(1):113-29. PubMed ID: 22543847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y; López-Ramos JC; Giménez-Llort L; Revilla S; Guerra R; Gruart A; Laferla FM; Cristòfol R; Delgado-García JM; Sanfeliu C
    J Alzheimers Dis; 2011; 24(3):421-54. PubMed ID: 21297257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-Seq analysis of frontal cortex and cerebellum from 5XFAD mice at early stage of disease pathology.
    Kim KH; Moon M; Yu SB; Mook-Jung I; Kim JI
    J Alzheimers Dis; 2012; 29(4):793-808. PubMed ID: 22507954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.
    Howlett DR; Richardson JC; Austin A; Parsons AA; Bate ST; Davies DC; Gonzalez MI
    Brain Res; 2004 Aug; 1017(1-2):130-6. PubMed ID: 15261108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection.
    Arisi I; D'Onofrio M; Brandi R; Felsani A; Capsoni S; Drovandi G; Felici G; Weitschek E; Bertolazzi P; Cattaneo A
    J Alzheimers Dis; 2011; 24(4):721-38. PubMed ID: 21321390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Stover KR; Brown RE
    Behav Brain Res; 2012 May; 231(1):75-85. PubMed ID: 22409975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Plasma microRNAs are Altered with Amyloidosis in a Mouse Model of Alzheimer's Disease.
    Ryan MM; Guévremont D; Mockett BG; Abraham WC; Williams JM
    J Alzheimers Dis; 2018; 66(2):835-852. PubMed ID: 30347618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.
    Pillay NS; Kellaway LA; Kotwal GJ
    Behav Brain Res; 2008 Oct; 192(2):173-7. PubMed ID: 18490064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.